受强制性开放获取政策约束的文章 - Jennifer M. Giltnane, MD, PhD了解详情
无法在其他位置公开访问的文章：1 篇
GDC-9545 (giredestrant): a potent and orally bioavailable selective estrogen receptor antagonist and degrader with an exceptional preclinical profile for ER+ breast cancer
J Liang, JR Zbieg, RA Blake, JH Chang, S Daly, AG DiPasquale, ...
Journal of Medicinal Chemistry 64 (16), 11841-11856, 2021
强制性开放获取政策： US Department of Energy, US National Institutes of Health
可在其他位置公开访问的文章：35 篇
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
S Mariathasan, SJ Turley, D Nickles, A Castiglioni, K Yuen, Y Wang, ...
Nature 554 (7693), 544-548, 2018
强制性开放获取政策： US National Institutes of Health
Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology …
S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ...
Advances in anatomic pathology 24 (6), 311-335, 2017
强制性开放获取政策： US National Institutes of Health, Government of Spain
Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor–positive breast cancer
R Jeselsohn, R Yelensky, G Buchwalter, G Frampton, F Meric-Bernstam, ...
Clinical cancer research 20 (7), 1757-1767, 2014
强制性开放获取政策： US National Institutes of Health
Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immunooncology …
S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ...
Advances in anatomic pathology 24 (5), 235-251, 2017
强制性开放获取政策： US National Institutes of Health
MYC and MCL1 cooperatively promote chemotherapy-resistant breast cancer stem cells via regulation of mitochondrial oxidative phosphorylation
K Lee, JM Giltnane, JM Balko, LJ Schwarz, AL Guerrero-Zotano, ...
Cell metabolism 26 (4), 633-647. e7, 2017
强制性开放获取政策： US National Institutes of Health, Government of Spain, Susan G. Komen
Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets
JM Balko, JM Giltnane, K Wang, LJ Schwarz, CD Young, RS Cook, ...
Cancer discovery 4 (2), 232-245, 2014
强制性开放获取政策： US National Institutes of Health
RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: therapeutic cooperation between MEK and PD-1/PD-L1 immune …
S Loi, S Dushyanthen, PA Beavis, R Salgado, C Denkert, P Savas, ...
Clinical Cancer Research 22 (6), 1499-1509, 2016
强制性开放获取政策： US National Institutes of Health, Susan G. Komen
Single-cell dynamics determines response to CDK4/6 inhibition in triple-negative breast cancer
US Asghar, AR Barr, R Cutts, M Beaney, I Babina, D Sampath, J Giltnane, ...
Clinical Cancer Research 23 (18), 5561-5572, 2017
强制性开放获取政策： Breast Cancer Now, UK, Cancer Research UK, National Institute for Health …
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
Z Kos, E Roblin, RS Kim, S Michiels, BD Gallas, W Chen, KK van de Vijver, ...
NPJ breast cancer 6 (1), 17, 2020
强制性开放获取政策： US Department of Defense, US National Institutes of Health, US Department of …
Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence
JM Balko, LJ Schwarz, N Luo, MV Estrada, JM Giltnane, ...
Science translational medicine 8 (334), 334ra53-334ra53, 2016
强制性开放获取政策： US National Institutes of Health, Susan G. Komen
Report on computational assessment of tumor infiltrating lymphocytes from the International Immuno-Oncology Biomarker Working Group
M Amgad, ES Stovgaard, E Balslev, J Thagaard, W Chen, S Dudgeon, ...
NPJ breast cancer 6 (1), 16, 2020
强制性开放获取政策： US Department of Defense, US National Institutes of Health, US Department of …
Association of FGFR1 with ERα maintains ligand-independent ER transcription and mediates resistance to estrogen deprivation in ER+ breast cancer
L Formisano, KM Stauffer, CD Young, NE Bhola, AL Guerrero-Zotano, ...
Clinical Cancer Research 23 (20), 6138-6150, 2017
强制性开放获取政策： US National Institutes of Health, Susan G. Komen
The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer
JD Joseph, B Darimont, W Zhou, A Arrazate, A Young, E Ingalla, K Walter, ...
Elife 5, e15828, 2016
强制性开放获取政策： US National Institutes of Health, Susan G. Komen
Genomic profiling of ER+ breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance
JM Giltnane, KE Hutchinson, TP Stricker, L Formisano, CD Young, ...
Science translational medicine 9 (402), eaai7993, 2017
强制性开放获取政策： US Department of Defense, US National Institutes of Health, Susan G. Komen
Inhibition of BMP signaling suppresses metastasis in mammary cancer
P Owens, MW Pickup, SV Novitskiy, JM Giltnane, AE Gorska, CR Hopkins, ...
Oncogene 34 (19), 2437-2449, 2015
强制性开放获取政策： US National Institutes of Health, US Department of Veterans Affairs
Analytic variability in immunohistochemistry biomarker studies
VK Anagnostou, AW Welsh, JM Giltnane, S Siddiqui, C Liceaga, ...
Cancer epidemiology, biomarkers & prevention 19 (4), 982-991, 2010
强制性开放获取政策： US National Institutes of Health
Evaluating feasibility of an automated 3-dimensional scanner using Raman spectroscopy for intraoperative breast margin assessment
G Thomas, TQ Nguyen, IJ Pence, B Caldwell, ME O’Connor, J Giltnane, ...
Scientific reports 7 (1), 13548, 2017
强制性开放获取政策： US Department of Defense
Kinome-wide functional screen identifies role of PLK1 in hormone-independent, ER-positive breast cancer
NE Bhola, VM Jansen, S Bafna, JM Giltnane, JM Balko, MV Estrada, ...
Cancer research 75 (2), 405-414, 2015
强制性开放获取政策： US National Institutes of Health, Susan G. Komen
Quantitative multiplexed analysis of ErbB family coexpression for primary breast cancer prognosis in a large retrospective cohort
JM Giltnane, CB Moeder, RL Camp, DL Rimm
Cancer 115 (11), 2400-2409, 2009
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定